{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:10:34Z","timestamp":1762078234462,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.amjcard.2010.10.010","type":"journal-article","created":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T04:10:32Z","timestamp":1294114232000},"page":"528-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Two-Year Safety and Effectiveness of Sirolimus-Eluting Stents (from a Prospective Registry)"],"prefix":"10.1016","volume":"107","author":[{"given":"Bimmer E.","family":"Claessen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin B.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giora","family":"Weisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Syros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary S.","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Franklin-Bond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Apostolidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose P.S.","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W.","family":"Moses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George D.","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2010.10.010_bib1","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2010.10.010_bib2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2010.10.010_bib3","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jacc.2009.04.077","article-title":"5-Year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents","volume":"54","author":"Caixeta","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2010.10.010_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa0706258","article-title":"A comparison of bare-metal and drug-eluting stents for off-label indications","volume":"358","author":"Marroquin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2010.10.010_bib5","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.297.18.2001","article-title":"Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents","volume":"297","author":"Win","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2010.10.010_bib6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/CIRCULATIONAHA.108.808311","article-title":"Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation","volume":"119","author":"Kimura","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2010.10.010_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCINTERVENTIONS.109.852178.109.852178","article-title":"Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries","volume":"2","author":"Lasala","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2010.10.010_bib8","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","article-title":"Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry","volume":"53","author":"van Werkum","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2010.10.010_bib9","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2010.10.010_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2010.10.010_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2010.10.010_bib12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jacc.2008.09.058","article-title":"2-Year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry)","volume":"53","author":"Kaltoft","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2010.10.010_bib13","first-page":"XVI","article-title":"Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (leaders): a randomised non-inferiority trial: 24 months follow-up","volume":"104","author":"Klauss","year":"2009","journal-title":"Am J Cardiol"},{"issue":"suppl","key":"10.1016\/j.amjcard.2010.10.010_bib14","first-page":"45B","article-title":"Two-year outcomes from the ENDEAVOR III trial: a randomized trial of the ENDEAVOR zotarolimus-eluting stent compared with the cypher sirolimus-eluting stent","volume":"49","author":"Leon","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"suppl","key":"10.1016\/j.amjcard.2010.10.010_bib15","doi-asserted-by":"crossref","first-page":"32A","DOI":"10.1016\/S0735-1097(03)80139-0","article-title":"Two-year follow-up of the RAVEL study: A randomized study with the sirolimus-eluting Bx VELOCITY stent in the treatment of patients with de-novo native coronary artery lesions","volume":"41","author":"Morice","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2010.10.010_bib16","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jacc.2005.05.102","article-title":"Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry","volume":"47","author":"Ong","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2010.10.010_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjcard.2008.03.053","article-title":"Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry)","volume":"102","author":"Roy","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2010.10.010_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amjcard.2006.01.049","article-title":"Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C\u2013SIRIUS with emphasis on late revascularizations and stent thromboses","volume":"98","author":"Schampaert","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2010.10.010_bib19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(10)60208-5","article-title":"Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial","volume":"375","author":"Rasmussen","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2010.10.010_bib20","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/eurheartj\/ehn021","article-title":"Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients","volume":"29","author":"Billinger","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2010.10.010_bib21","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1136\/hrt.2009.172379","article-title":"Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results","volume":"95","author":"Byrne","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2010.10.010_bib22","first-page":"327","article-title":"Comparison of 2-year clinical outcomes with sirolimus and paclitaxel-eluting stents for patients with diabetes: results of the Registro Regionale AngiopLastiche Emilia-Romagna Registry","volume":"75","author":"Balducelli","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2010.10.010_bib23","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jcin.2009.10.008","volume":"2","author":"Leon","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2010.10.010_bib24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/eurheartj\/ehp599","article-title":"Randomized comparison of everolimus- and paclitaxel-eluting stents: pooled analysis of the 2-year clinical follow-up from the SPIRIT II and III trials","volume":"31","author":"Onuma","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2010.10.010_bib25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MCA.0b013e3282ef5b40","article-title":"Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels","volume":"18","author":"Hoffmann","year":"2007","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.amjcard.2010.10.010_bib26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.amjcard.2008.04.041","article-title":"Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts","volume":"102","author":"Okabe","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2010.10.010_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4244\/EIJV4I3A57","article-title":"Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts","volume":"4","author":"van Twisk","year":"2008","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2010.10.010_bib28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.CIR.100.8.789","article-title":"Late coronary occlusion after intracoronary brachytherapy","volume":"100","author":"Costa","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2010.10.010_bib29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.CIR.100.8.780","article-title":"Late thrombosis after radiation","volume":"100","author":"Waksman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2010.10.010_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ahj.2008.08.025","volume":"157","author":"Rahel","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2010.10.010_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehl412","article-title":"The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus","volume":"28","author":"Daemen","year":"2007","journal-title":"Eur Heart J"},{"issue":"suppl","key":"10.1016\/j.amjcard.2010.10.010_bib32","first-page":"210L","article-title":"Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI 2 years results) (abstract)","volume":"100","author":"Menichelli","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2010.10.010_bib33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jacc.2007.04.029","article-title":"Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb\/IIIa inhibitor infusion in patients with myocardial infarction: results from the STRATEGY study","volume":"50","author":"Valgimigli","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2010.10.010_bib34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4244\/EIJV3I4A81","article-title":"Three-year follow-up of the ARTS-II#\u2014sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease","volume":"3","author":"Serruys","year":"2008","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2010.10.010_bib35","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMoa1001266","article-title":"Duration of dual antiplatelet therapy after implantation of drug-eluting stents","volume":"362","author":"Park","year":"2010","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491002093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491002093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:01:51Z","timestamp":1762077711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291491002093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S000291491002093X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2010.10.010","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-Year Safety and Effectiveness of Sirolimus-Eluting Stents (from a Prospective Registry)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2010.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}